StockData
Azitra, Inc. logo

Azitra, Inc. (AZTR) stock

AZTRNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 1/30
$0.57−0.04 (-6.20%)

Close on Nov 18, 2026Market cap $34.56MP/E –Yield –

Azitra revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Azitra's revenue for the twelve months ending Dec 31, 2025 was $0, down 100.0% year over year. For fiscal 2025 it was $0, down 100.0% from the year before.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$0-100.0%
FY2024Dec 31, 2024$7.50K-98.9%
FY2023Dec 31, 2023$686.00K+141.5%
FY2022Dec 31, 2022$284.00K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025$0–
Q3 FY2025Sep 30, 2025$0-100.0%
Q2 FY2025Jun 30, 2025$0–
Q4 FY2024Dec 31, 2024$0-100.0%
Q3 FY2024Sep 30, 2024$0-100.0%
Q2 FY2024Jun 30, 2024$7.50K-95.6%
Q1 FY2024Mar 31, 2024$0-100.0%
Q4 FY2023Dec 31, 2023$90.00K+195.1%
Q3 FY2023Sep 30, 2023$310.70K+540.6%
Q2 FY2023Jun 30, 2023$172.00K+102.4%
Q1 FY2023Mar 31, 2023$113.30K–
Q4 FY2022Dec 31, 2022$30.50K–
Q3 FY2022Sep 30, 2022$48.50K–
Q2 FY2022Jun 30, 2022$85.00K–

More Azitra figures

See a number that looks wrong?